EN
HI
Astrazeneca Pharma India Chart
Astrazeneca Pharma India Share Key Metrics
Volume
9272.00
Market Cap
20922.50 CR
LTQ@LTP
1@8236.50
ATP
8255.44
Var Margin
16.1 %
Circuit Range
6695.5-10042.5
Delivery %
48.56 %
Value
7.65 CR
ASM/GSM
No
Market Lot
1
Summary
Astrazeneca Pharma India share price stands at ₹8236.5 at 30 Apr, 2026 | 14:51. The stock Astrazeneca Pharma India intraday movement has stayed between ₹8102.00 and ₹8465.50, while on a 52-week basis it has fluctuated from ₹7551.50 to ₹10691.00.
In terms of trading activity, Astrazeneca Pharma India has recorded a volume of 9272 shares. The Astrazeneca Pharma India has a market cap of ₹25000000. The stock’s Average Traded Price (ATP) stands at ₹825544, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 823650.
The Astrazeneca Pharma India operates within a circuit range of ₹6695.5-10042.5 – ₹6695.5-10042.5, with a Value of ₹7.65 CR. The Delivery Percentage for the day is 48.56%. Additionally, Astrazeneca Pharma India currently falls under the No framework, and trades with a market lot size of 1.
Astrazeneca Pharma India Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.93
Sector P/B
3.52
Sec. Div. Yield
0.57
Astrazeneca Pharma India Resistance and Support
Pivot 8412.67
Resistance
First Resistance
8505.34
Second Resistance
8641.67
Third Resistance
8734.34
Support
First Support
8276.34
Second Support
8183.67
Third Support
8047.34
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
Astrazeneca Pharma India News
AstraZeneca Pharma India Limited
AstraZeneca Pharma India received permission to import, sell, and distribute Acalabrutinib tablets (Calquence®) for an additional indication in India. This approval targets previously untreated chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL), to be used in combination with venetoclax with or without obinutuzumab.
Apr 10 2026 17:04:00
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited is conducting a postal ballot for shareholder approval to shift its registered office from Karnataka to Maharashtra. This move aims to enhance administrative and operational efficiency for the company.
Apr 10 2026 17:04:00
Read More
About Astrazeneca Pharma India
NSE : 5610
BSE : 506820
ISIN : INE203A01020
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Shilpa Divekar Nirula | Chairperson |
| Revathy Ashok | Non Executive Independent Director |
Astrazeneca Pharma India Similar Stocks
Piramal Pharma Ltd.
162.36
2.21 (1.38%)
Acutaas Chemicals Ltd.
2556.30
53.90 (2.15%)
Onesource Specialty Pharma Ltd.
1740.20
-22.30 (1.27%)
Natco Pharma Ltd.
1099.35
5.75 (0.53%)
Cohance Lifesciences Ltd.
483.00
15.45 (3.30%)
Neuland Laboratories Ltd.
14986.00
330.00 (2.25%)
Eris Lifesciences Ltd.
1326.90
10.70 (0.81%)
Granules India Ltd.
694.00
-10.55 (1.50%)
Poly Medicure Ltd.
1510.40
-7.50 (0.49%)
Jubilant Pharmova Ltd.
928.40
1.55 (0.17%)
Astrazeneca Pharma India FAQs
The Buying Price of Astrazeneca Pharma India share is 8236.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 64.93 & 3.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astrazeneca Pharma India is 20922.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astrazeneca Pharma India share price is 10691.00 & 7551.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astrazeneca Pharma India belongs to the Healthcare sector.
